PropertyValue
is ?:annotates of
?:citedBy
  • -1
?:creator
?:doi
  • 10.4155/bio-2020-0188
?:doi
?:hasPublicationType
?:journal
  • Bioanalysis
is ?:pmid of
?:pmid
?:pmid
  • 33326307
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.793
?:rankingScore_hIndex
  • 46
?:title
  • China NMPA perspective on clinical evaluation of SARS-CoV-2 antibody test reagents in the process of emergency approval.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all